Sylvie BOYER
Sylvie BOYER
Chercheur économie de la santé
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...
The lancet HIV 5 (3), e116-e125, 2018
1132018
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon …
C Laurent, C Kouanfack, G Laborde-Balen, AF Aghokeng, JBT Mbougua, ...
The Lancet infectious diseases 11 (11), 825-833, 2011
1112011
Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors
S Boyer, I Clerc, CR Bonono, F Marcellin, PC Bilé, B Ventelou
Social science & medicine 72 (8), 1383-1392, 2011
1082011
The point-of-care laboratory in clinical microbiology
M Drancourt, A Michel-Lepage, S Boyer, D Raoult
Clinical microbiology reviews 29 (3), 429-447, 2016
972016
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial …
CC Iwuji, J Orne-Gliemann, F Tanser, S Boyer, RJ Lessells, F Lert, J Imrie, ...
Trials 14 (1), 230, 2013
952013
Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon
S Boyer, F Eboko, M Camara, C Abé, MEO Nguini, S Koulla-Shiro, ...
Aids 24, S5-S15, 2010
902010
HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study
S Loubiere, P Peretti-Watel, S Boyer, J Blanche, SC Abega, B Spire
Social science & medicine 69 (6), 885-891, 2009
762009
Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey
S Boyer, F Marcellin, P Ongolo-Zogo, SC Abega, R Nantchouang, B Spire, ...
Bulletin of the World Health Organization 87, 279-287, 2009
742009
Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12‐116)
F Marcellin, S Boyer, C Protopopescu, A Dia, P Ongolo‐Zogo, ...
Tropical medicine & international health 13 (12), 1470-1478, 2008
732008
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110 …
S Boyer, L March, C Kouanfack, G Laborde-Balen, P Marino, ...
The Lancet infectious diseases 13 (7), 577-586, 2013
552013
The impact of universal test and treat on HIV incidence in a rural South African population: ANRS 12249 TasP trial, 2012-2016
C Iwuji, J Ome-Gliemann, E Balestre, J Larmarange, R Thiebaut, F Tanser, ...
Journal of the International AIDS Society 19 (5), 2016
532016
Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers
S Loubiere, S Boyer, C Protopopescu, CR Bonono, SC Abega, B Spire, ...
Health policy 92 (2-3), 165-173, 2009
532009
Relationship between Charcot-Marie-Tooth 1A and Smith-Magenis regions. snU3 may be a candidate gene for the Smith-Magenis syndrome
C Chevillard, DL Paslier, E Passage, P Ougen, A Billault, S Boyer, ...
Human molecular genetics 2 (8), 1235-1243, 1993
481993
Performance of HIV care decentralization from the patient’s perspective: health-related quality of life and perceived quality of services in Cameroon
S Boyer, C Protopopescu, F Marcellin, MP Carrieri, S Koulla-Shiro, ...
Health policy and planning 27 (4), 301-315, 2012
462012
Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods
P Roux, C Kouanfack, J Cohen, F Marcellin, S Boyer, E Delaporte, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 57, S40-S43, 2011
462011
Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the S tratall ANRS 12110/ESTHER trial in C ameroon
M Meresse, L March, C Kouanfack, RC Bonono, S Boyer, ...
HIV medicine 15 (8), 478-487, 2014
422014
Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey)
A Dia, F Marcellin, RC Bonono, S Boyer, AD Bouhnik, C Protopopescu, ...
Sexually transmitted infections 86 (2), 148-154, 2010
372010
Dolutegravir-based or low-dose Efavirenz–based regimen for the treatment of HIV-1
NAMSAL ANRS 12313 Study Group
New England Journal of Medicine 381 (9), 816-826, 2019
352019
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal
J Orne-Gliemann, J Larmarange, S Boyer, C Iwuji, N McGrath, ...
BMC public health 15 (1), 209, 2015
322015
Gender differences in adherence and response to antiretroviral treatment in the Stratall trial in rural district hospitals in Cameroon
C Boullé, C Kouanfack, G Laborde-Balen, S Boyer, AF Aghokeng, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 355-364, 2015
312015
The system can't perform the operation now. Try again later.
Articles 1–20